2009 Komen NC Triangle Race for the Cure

June 13, 2009 | Meredith College

The Komen NC Triangle Race for the Cure® is the largest foot-race in North Carolina, attracting more than 24,000 walkers, runners and spectators in 2008. Now in its 13th year, this event has raised more than $10 million to support breast cancer research, education, screening and treatment programs.


We are currently accepting sponsors for the 2009 Race
For inquiries please e-mail: sponsorship@komennctringle.org

Thanks to our 2009 Local Presenting Sponsor

And our 2009 Spotlight Media Sponsors

Donate to Spirit of Komen

Remembering Our Founder

Remembering Our Founder

(Read More)
Share your memories of Jeanne

Share your memories of Jeanne

(Read More)

Breast Cancer News

Jun 22, 2009 Oncotype DX® and Clinical Characteristics Influence Chemotherapy Decisions in Early Breast Cancer

According to research conducted at the Dana-Farber Cancer Institute, among women with early breast cancer who underwent testing with Oncotype DX®, decisions about the need for chemotherapy were influenced by the Oncotype DX recurrence score as well as by the size and grade of the cancer. These results were presented at the 2009 annual meeting of the American Society of Clinical Oncology.

Jun 15, 2009 Denosumab Provides Bone Benefits in Prostate and Breast Cancer

Among prostate patients treated with androgen deprivation therapy, the investigational drug denosumab increases bone density and reduces the risk of fractures. Denosumab also improves bone density in breast cancer patients treated with aromatase inhibitors. These were the results of two studies presented at the 2009 annual meeting the American Society of Clinical Oncology (ASCO).

Jun 10, 2009 Partial Breast Irradiation Appears Safe and Feasible for Early Breast Cancer

Partial breast irradiation (PBI) appears to produce the same overall survival results as whole-breast radiation (WBRT) in women with early-stage breast cancer; however, more research will be necessary before this investigational treatment replaces WBRT as the standard of care in this patient group. The results of this study were presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida.